Search

Your search keyword '"SONG Yan"' showing total 49 results

Search Constraints

Start Over You searched for: Author "SONG Yan" Remove constraint Author: "SONG Yan" Journal blood Remove constraint Journal: blood
49 results on '"SONG Yan"'

Search Results

2. C1Q labels a highly aggressive macrophage-like leukemia population indicating extramedullary infiltration and relapse

3. Economic Burden and Treatment Patterns Among Patients with Mantle Cell Lymphoma in the US: A Retrospective Claims Analysis

4. Real-World Treatment Patterns, Healthcare Resource Use, and Costs Among Patients with Diffuse Large B-Cell Lymphoma: A Retrospective Analysis of US Claims Data

5. Clinical Outcomes Following Allogeneic Hematopoietic Cell Transplantation with Omidubicel or Other Donor Sources in Patients with Hematologic Malignancies: Comparison of Clinical Trial Results to Center for International Blood and Marrow Transplant Research Database Controls

10. A High Throughput Quantitative Seroproteomics Analysis of Multiple Myeloma Patients on Tagraxofusp Therapy Identifies Novel Cytokine-Assisted Mechanism of Action

24. Sumoylation of Pyruvate Kinase M2 Inhibits Myeloid Differentiation in Hematopoietic Cells

25. Identification and Validation of HLA-A24 XBP1us, XBP1sp, CD138, and CS1 Peptides to Generate Antigens Specific-Cytotoxic T Lymphocytes: Preclinical Basis for Vaccine Therapy in HLA-A24 Patients with Multiple Myeloma and Other Cancers

40. SL-401, a Novel Targeted Therapy Directed to the Interleukin-3 Receptor (IL-3R), Blocks Plasmacytoid Dendritic Cell (pDC)-Triggered Myeloma Cell Growth and Prevents Osteoclastogenesis

43. Anti-Myeloma Activity of a Novel Free Radical Inducer Rrx-001

45. Serum 2-Hydroxyglutarate Level Is a Prognostic Marker in Acute Myeloid Leukemia

46. Proteomic Analysis Identifies Mechanism(s) of Overcoming Bortezomib-Resistance ViaTargeting Ubiquitin Receptor Rpn13

48. Oral Proteasome Inhibitor Marizomib and IMiD® Imunomodulatory Drug Pomalidomide Trigger Synergistic Anti-Myeloma Activity and Enhanced Proteasome Inhibition in Vitroand In Vivo

49. A distinct glucose metabolism signature of acute myeloid leukemia with prognostic value.

Catalog

Books, media, physical & digital resources